DS
INDV icon

David Shaw’s Indivior Pharmaceuticals INDV Stock Holding History

David Shaw’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.68M Buy
236,034
+32,049
+16% +$1.16M ﹤0.01% 1835
2026
Q1 		$6.22M Buy
203,985
+33,118
+19% +$1.09M ﹤0.01% 2017
2025
Q4 		$6.13M Sell
170,867
-42,387
-20% -$1.29M ﹤0.01% 2140
2025
Q3 		$5.14M Buy
213,254
+118,621
+125% +$2.48M ﹤0.01% 2183
2025
Q2 		$1.39M Buy
94,633
+26,529
+39% +$309K ﹤0.01% 3005
2025
Q1 		$649K Sell
68,104
-31,502
-32% -$331K ﹤0.01% 3348
2024
Q4 		$1.24M Buy
+99,606
New +$1.02M ﹤0.01% 3084

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's INDV Position: Q2 2026 in Review

David Shaw increased its Indivior Pharmaceuticals (INDV) stake by 16% in Q2 2026, buying an estimated $1.16M and bringing the position to 236,034 shares worth $9.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

David Shaw first reported a position in INDV in Q4 2024 and has held it in 7 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • David Shaw held 236,034 shares of Indivior Pharmaceuticals worth $9.68M as of Q2 2026.
  • David Shaw bought 32,049 Indivior Pharmaceuticals shares in Q2 2026, an estimated $1.16M.
  • Indivior Pharmaceuticals made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1835 holding.
  • David Shaw first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.